Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | RHEB | Q15382 | 1/20 | 0.35 |
| ▸ | BRAF | P15056 | 7/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.33 |
| ▸ | SELE | P16581 | 2/20 | 0.33 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 3/20 | 0.33 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7881490 | 0.99 | FFAR1 (0.36) | FFAR1RHEBBRAFSLC6A2SLC6A4 | |
| SCHEMBL7882372 | 0.91 | FFAR1 (0.39) | FFAR1RHEBBRAFBRD4FBP1 | |
| SCHEMBL7880729 | 0.89 | FFAR1 (0.35) | FFAR1RHEBBRAFSLC6A2SLC6A4 | |
| SCHEMBL7882112 | 0.89 | BRAF (0.34) | FFAR1RHEBBRAFICAM1SELE | |
| SCHEMBL7882124 | 0.89 | BRAF (0.35) | FFAR1RHEBBRAFSLC6A2SLC6A4 | |
| SCHEMBL7878053 | 0.89 | SLC6A4 (0.40) | FFAR1RHEBBRAFSLC6A2SLC6A4 | |
| SCHEMBL7881879 | 0.88 | ICAM1 (0.32) | FFAR1RHEBBRAFICAM1SELE | |
| SCHEMBL7877744 | 0.88 | HSPB1 (0.36) | FBP1 | |
| SCHEMBL7873263 | 0.87 | HTR2A (0.37) | FFAR1RHEBBRAFSLC6A4ICAM1 | |
| SCHEMBL7873759 | 0.86 | SCN9A (0.37) | FFAR1SLC6A2SLC6A4SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |